Moleculin Biotech Inc (MBRX)
5.08
+0.05
(+0.99%)
USD |
NASDAQ |
May 17, 16:00
5.08
0.00 (0.00%)
After-Hours: 20:00
Moleculin Biotech Shareholders Equity (Quarterly): 21.59M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 21.59M |
December 31, 2023 | 26.07M |
September 30, 2023 | 35.14M |
June 30, 2023 | 40.27M |
March 31, 2023 | 45.68M |
December 31, 2022 | 52.19M |
September 30, 2022 | 58.42M |
June 30, 2022 | 66.36M |
March 31, 2022 | 72.66M |
December 31, 2021 | 78.99M |
September 30, 2021 | 81.26M |
June 30, 2021 | 84.70M |
March 31, 2021 | 88.52M |
December 31, 2020 | 17.76M |
September 30, 2020 | 14.47M |
June 30, 2020 | 15.63M |
March 31, 2020 | 15.29M |
Date | Value |
---|---|
December 31, 2019 | 15.57M |
September 30, 2019 | 18.98M |
June 30, 2019 | 22.09M |
March 31, 2019 | 14.68M |
December 31, 2018 | 14.27M |
September 30, 2018 | 14.97M |
June 30, 2018 | 16.75M |
March 31, 2018 | 20.57M |
December 31, 2017 | 17.12M |
September 30, 2017 | 18.65M |
June 30, 2017 | 19.27M |
March 31, 2017 | 16.14M |
December 31, 2016 | 14.96M |
September 30, 2016 | 16.24M |
June 30, 2016 | 17.23M |
March 31, 2016 | -0.6883M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
14.47M
Minimum
Sep 2020
88.52M
Maximum
Mar 2021
43.58M
Average
37.70M
Median
Shareholders Equity (Quarterly) Benchmarks
Merck & Co Inc | 40.36B |
Lixte Biotechnology Holdings Inc | 3.126M |
Moderna Inc | 12.82B |
NovaBay Pharmaceuticals Inc | 0.16M |
Palatin Technologies Inc | 1.579M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 30.84M |
Total Liabilities (Quarterly) | 9.258M |